true

{"AlternateComparison":false,"RelatedProducts":false,"Specification":true,"FeatureBenefit":false}

MaxPlus™ Needle-free connectors MaxPlus™ Needle-free Connectors

SKU:

MP1000

GTIN:

10885403232985

MaxPlus™ Needle-free Connector

Name: MaxPlus™ Needle-free Connector
Brand: MaxPlus™
SKU: MP1000

Hospitals using the MaxPlus™ Needle-free Connector had lower unadjusted CLABSI rates, as well as lower standardized infection ratios, compared to hospitals not using the MaxPlus™ Needle-free Connector.*

true

FEATURE AND BENEFIT CARDS NOT AVAILABLE

false

GTIN

GTIN - Case

50885403232983

100

GTIN - each

10885403232985

GTIN - Multi case

20885403232982

2400

FDA, Premarket Approval, and Regulatory

Natural Latex

Registered with Health Canada

Yes

Manufacturing

Country of Manufacture

Mexico

CE Marking

Packaging

Case Dimensions

6.25in x 6.25in x 5.5in 1.1lb

Quantity

100

Unit of Measure

Per case

Product Basic Specification

Weight

1.1 lbs

Approximate Length

0 cm

Approximate Priming Volume

0.28 mL

Manifold

None

Number of Backcheck Valves

Number of Connectors

Number of Fuses

Pressure Rated

Yes

Sterility

Content sterile

Stock

None

Color of Tubing

None

T-Connector Type

None

Number of Y-Sites

Y-Site Port Type

None

Type of Connector

MaxPlus™

Filter

None

GTIN

GTIN - Case	50885403232983	100
GTIN - each	10885403232985	1
GTIN - Multi case	20885403232982	2400

FDA, Premarket Approval, and Regulatory

Natural Latex	No
Registered with Health Canada	Yes

Manufacturing

Country of Manufacture	Mexico
CE Marking	No

Packaging

Case Dimensions	6.25in x 6.25in x 5.5in 1.1lb
Quantity	100
Unit of Measure	Per case

Product Basic Specification

Weight	1.1 lbs
Approximate Length	0 cm
Approximate Priming Volume	0.28 mL
Manifold	None
Number of Backcheck Valves	0
Number of Connectors	1
Number of Fuses	0
Pressure Rated	Yes
Sterility	Content sterile
Stock	None
Color of Tubing	None
T-Connector Type	None
Number of Y-Sites	0
Y-Site Port Type	None
Type of Connector	MaxPlus™
Filter	None

true

BD’s collection of literature on industry and on our offerings give you information you can use to continue striving for excellence.

Learn more

BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events which excel in advancing the world of health™.

Learn more

false

RELATED PRODUCTS NOT AVAILABLE

North American Regional Complaint Center

1-844-8BD-LIFE (1-844-823-5433)

productcomplaints@bd.com

Things to Consider

If you are a patient or end user, you can contact us yourself, or you may have your caregiver or your physician do that for you. To help us process your
information quickly and effectively, please contact our customer complaints
team.

To better facilitate our investigation, please include the following information in your reporting:

Product Name and/or Catalog Number
Lot Number or Serial Number
Any injuries and/or Harm?
What is the issue you experienced?
Is the actual sample or sample representative available? (If possible, please send affected sample)
Contact name and phone number

Tabak YP, Jarvis WR, Sun X, Crosby CT, Johannes RS. Meta-analysis on central line-associated bloodstream infections associated with a needleless intravenous connector with a new engineering design. Am J Infect Control. 2014;42(12):1278–1284. doi: 10.1016/j.ajic.2014.08.018.
Williams A. Catheter occlusion in home infusion: the influence of needleless connector design on central catheter occlusion. J Infus Nurs. 2018;41(1):52–57. doi: 10.1097/NAN.0000000000000259.
Tabak YP, Johannes RS, Sun X, Crosby CT, Jarvis WR. Innovative use of existing public and private data sources for postmarketing surveillance of central line-associated bloodstream infections associated with intravenous needleless connectors. J Infus Nurs. 2016;39(5):328–335. doi: 10.1097/NAN.0000000000000185.
Costello JM, Morrow DF, Graham DA, Potter-Bynoe G, Sandora TJ, Laussen PC. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics. 2008;121(5):915–923. doi: 10.1542/peds.2007-1577.
Wallace MC, Macy DL. Reduction of central line-associated bloodstream infection rates in patients in the adult intensive care unit. J Infus Nurs. 2016;39(1):47–55. doi: 10.1097/NAN.0000000000000151.
Sandora TJ, Graham DA, Conway M, Dodson B, Potter-Bynoe G, Margossian SP. Impact of needleless connector change frequency on central line-associated bloodstream infection rate. Am J Infect Control. 2014;42(5):485–489. doi: 10.1016/j.ajic.2014.01.022.
Royer T. Implementing a better bundle to achieve and sustain a zero central line-associated bloodstream infection rate. J Infus Nurs. 2010;33(6):398–406. doi: 10.1097/NAN.0b013e3181f8586b.
Casey AL, Karpanen TJ, Nightingale P, Chaganti S, Elliott TSJ. Microbiologic contamination of a positive- and a neutral-displacement needleless intravenous access device in clinical use. Am J Infect Control. 2016;44(12):1678–1680. doi: 10.1016/j.ajic.206.06.027.
Clavier T, Ferguen M, Gouin P, et al. Impact of MaxZero™ needle-free connector on the incidence of central venous catheter-related infections in surgical intensive care unit. Aust Crit Care. 2019;32(2):107–111. doi: 10.1016/j.aucc.2018.03.003.
Hankins R, Majorant OD, Rupp ME, et al. Microbial colonization of intravascular catheter connectors in hospitalized patients. Am J Infect Control. 2019;47(12):1489–1492. doi: 10.1016/j.ajic.2019.05.024.
BD MaxPlus™ Needle-free Connector Directions for Use. 630-00658; 2015.
Gorski LA, Hadaway L, Hagle ME, et al. Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021;44(1S,1):S1–S224. doi: 10.1097/NAN.0000000000000396.
International Nosocomial Infection Control Consortium (INICC) Care bundles to prevent central and peripheral line-related bloodstream infections. INICC website. http://www.inicc.org/media/docs/2017-INICCBSIPreventionGuidelines.pdf. Published January 1, 2017. Accessed June 2, 2021.
González López J, Arribi Vilela A, Fernández Del Palacio E, et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117–126. doi: 10.1016/j.jhin.2013.10.008.
Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs. 2010;33(6):371–384.doi: 10.1097/NAN.0b013e3181f85be2.
Hadaway L. Needleless connectors for IV catheters. Am J Nurs. 2012;112(11):32–44. doi: 10.1097/01.NAJ.0000422253.72836.c1.
Curran E. Needleless connectors: the vascular access catheter’s microbial gatekeeper. J Infect Prev. 2016;17(5):234–240. doi: 10.1177/1757177416657164.
Guenezan J, Marjanovic N, Drugeon B, et al. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial. Lancet Infect Dis. 2021. doi: 10.1016/S1473-3099(20)30738-6.

BD-27572

true